Published by Josh White on 23rd October 2020
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Friday that all necessary regulatory approvals had now been received for the 'STAR' trial of SFX-01 treatment for Acute Respiratory Infections.
URL: http://www.digitallook.com/dl/news/story/31343661/...